Free Trial

180 Life Sciences (ATNFW) Competitors

180 Life Sciences logo
$0.0090 0.00 (0.00%)
(As of 11/20/2024 ET)

ATNFW vs. LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, BTMDW, and BCTXW

Should you be buying 180 Life Sciences stock or one of its competitors? The main competitors of 180 Life Sciences include 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

180 Life Sciences vs.

4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings.

In the previous week, 4D pharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
4D pharma Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

4D pharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
4D pharmaN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

4D pharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get 180 Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATNFW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATNFW vs. The Competition

Metric180 Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$164.86M$5.07B$8.80B
Dividend YieldN/A3.25%4.99%4.07%
P/E RatioN/A329.4789.5613.60
Price / SalesN/A14,996.331,224.8087.40
Price / CashN/A11.6739.4536.27
Price / BookN/A7.126.976.33
Net IncomeN/A-$18.52M$119.04M$225.93M
7 Day PerformanceN/A-0.24%-1.78%-0.96%
1 Month PerformanceN/A8.09%-3.59%1.06%
1 Year PerformanceN/A26.32%31.64%26.59%

180 Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-25.0%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-20.6%
N/A-71.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$3.10
-7.7%
N/A+105.3%$0.00$306.77M0.004
ALVO
Alvotech
2.2902 of 5 stars
$12.33
-0.7%
$18.00
+46.0%
+35.9%$0.00$93.38M-6.711,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.08
flat
N/A+77.4%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.05
-11.7%
N/A+179.9%$0.00$35.24M0.0070
BTMDW
biote
N/A$0.50
flat
N/AN/A$0.00$187.23M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.33
-7.1%
N/A-80.6%$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:ATNFW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners